Search
-
News
MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.
… Tuesday, December 17, 2024 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights
-
News
Memorial Sloan Kettering Cancer Center recently published two retrospective studies with practice-changing insights for improving the treatment and surveillance of patients with oropharyngeal cancer.
… Friday, December 19, 2025 Teams of head and neck radiation oncologists, surgical oncologists and medical oncologists at Memorial Sloan Kettering Cancer Center (MSK) recently published two retrospective studies with practice-changing insights for improving the treatment and surveillance of patients with
-
News
Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented biennially by Memorial Sloan Kettering to honor promising scientists under the age of 46.
… Tuesday, September 20, 2011 Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented
-
Partnering Opportunities
Uniting MSK’s research and clinical expertise with AWS’s advanced cloud technologies is a bold step towards addressing one of the world’s most pressing health challenges.
… Monday, March 10, 2025 Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the power of artificial intelligence (AI), high performance computing (HPC), and other
-
News
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
… Wednesday, September 16, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Forbes Names Memorial Sloan Kettering Cancer Center #2 Best Employer in New York State Memorial Sloan Kettering Cancer Center MSK was named the second-best employer in New York
-
News
The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD, Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes of Health Director’s New Innovator Award, has served as host for past sessions of the online seminar series for the scientific community.
… Monday, May 4, 2020 The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD , Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes
-
News
Researchers shed light on how aberrant cell division can cause the kind of mutations often found in cancer cells.
… Thursday, August 27, 2020 VIDEO | 00:16 Separation Anxiety: Cell Division Gone Awry Leads to Genetic Chaos This video shows the effects of telomere crisis during cell division. As a cell attempts to divide, a tug-of-war develops over the chromosome (narrow strand) as each daughter cell tries to claim
-
News
An MSK research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests.
… Wednesday, October 1, 2025 Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a microscopic level within the abdomen early on, resulting in diagnosis at an advanced stage. Additionally, while initial treatments with surgery, chemotherapy
-
News
David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”
… Wednesday, June 3, 2020 David Solit, MD , Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology , is the featured speaker for the June 3 episode of “MSK Science Spotlight.” Dr. Solit, a physician-scientist who studies human oncology and pathogenesis, genomics, oncogenes and tumor
-
News
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
… Friday, November 1, 2024 If you have been diagnosed with lung cancer, where you go first matters — and so does knowing what questions to ask your care team. There have been remarkable strides in understanding and treating lung cancer over the past two decades, from better screening procedures to lifesaving